Ser7
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser7  -  p16-INK4A (human)

Site Information
_MEPAAGssMEPSAD   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 448829

In vivo Characterization
Methods used to characterize site in vivo:
[32P] bio-synthetic labeling ( 3 ) , immunoprecipitation ( 3 ) , mutation of modification site ( 2 , 3 ) , peptide sequencing ( 3 ) , phospho-antibody ( 1 ) , phosphoamino acid analysis ( 3 ) , western blotting ( 1 )
Disease tissue studied:
bone cancer ( 2 )
Relevant cell line - cell type - tissue:

Upstream Regulation
Putative in vivo kinases:
ATR (human) ( 1 )
Treatments:
siRNA ( 1 ) , UV ( 1 )

Downstream Regulation
Effects of modification on p16-INK4A:
protein stabilization ( 1 )

References 

1

Al-Khalaf HH, Hendrayani SF, Aboussekhra A (2011) The atr protein kinase controls UV-dependent upregulation of p16INK4A through inhibition of Skp2-related polyubiquitination/degradation. Mol Cancer Res 9, 311-9
21270107   Curated Info

2

Guo Y, Yuan C, Weghorst CM, Li J (2010) IKKbeta specifically binds to P16 and phosphorylates Ser8 of P16. Biochem Biophys Res Commun 393, 504-8
20152798   Curated Info

3

Gump J, Stokoe D, McCormick F (2003) Phosphorylation of p16INK4A correlates with Cdk4 association. J Biol Chem 278, 6619-22
12529334   Curated Info